ARKG: Market May Ridicule ARK, But You Shouldn't Ignore Their Genomics ETF (Archive)
ARKG is bottoming after a brutal bubble-pop, with powerful genomics tailwinds building.
This 5-Minute Pitch was originally published on Seeking Alpha before the launch of the Hunting Alphas website. It is shared here to showcase my previous work and track record. New 5-Minute Pitches published on this site will not be disseminated anywhere else.
Elevator Pitch
- ARK Invest does great deep-dive research. Utilize their insights along with market timing considerations to generate alpha.
- The performance of ARKG is dictated mostly by interest rate decisions in the current environment. But underneath the macro layer, there are many promising tailwinds germinating in the background.
- I believe ARKG is bottoming out, and you should be waiting for the last few triggers to materialize to initiate a buy position.
Read the full article here.
Disclosures and Disclaimers
Past performance ≠ future results. Not investment advice. See full Disclaimer.
Comments ()